Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Global Harmonization Task Force

Global Harmonization Task Force

BACK

Global Harmonization Task Force

Mission: Inform and educate regulatory agencies around the world to ensure harmonized adoption of in silico methods

Global harmonization of regulatory frameworks is one of the leading barriers to broader adoption of digital evidence.

The Global Harmonization Task Force (GHTF) is working globally to converge towards a common framework that could eventually harmonize the different regulations. This includes developing position papers that outline best practices based on existing frameworks. These documents are available in multiple languages to ensure the correct comprehension of these practices. GHTF members participate in conferences, workshops, etc. to socialize these practices with stakeholders in engineering, quality, and regulatory affairs professionals.

The GHTF is also engaging directly with global competent authorities to socialize and educate stakeholders regarding the benefits of digital evidence to the healthcare industry and patients.

Goals

  • Lobby for a globally harmonized approach.
  • Engage directly with regulators from IMDRF members countries to inform and align.
  • Address regulatory uncertainty through the development of a globally recognized standard and/or guidance document

Multilingual Focus Documents

Tina Morrison

Tina Morrison

Co-Chair of the Global Harmonization Task Force

Vice President of Scientific Strategy EQTYLab

READ BIO

NEWS

News Avicenna Alliance publishes the 5th Release of its In Silico Glossary

Avicenna Alliance publishes the 5th Release of its In Silico Glossary

The Avicenna Alliance ispleased to announce the publication of the 5th Release of the Avicenna …

News Computational Modeling and Simulation of Medical Devices - Book Release

Computational Modeling and Simulation of Medical Devices - Book Release

The medical device industry is increasingly adopting computational modeling and simulation (CM&S) throughout the product life cycle—from early-stage design and prototyping to regulatory submissions and post-market performance evaluation. A key challenge across all these applications is establishing whether a model is sufficiently credible to support (regulatory) decision-making. The ASME V&V 40 standard, published in 2018, introduced a risk-based framework for assessing model credibility and has gained broad acceptance across the industry.

News BSI Joins the Avicenna Alliance to Advance Trust in In Silico Medicine

BSI Joins the Avicenna Alliance to Advance Trust in In Silico Medicine

The Avicenna Alliance is delighted to welcome the British Standards Institution (BSI) – …

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2026 Avicenna Alliance | powered by We Berry